Open AccessSerum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
Author(s) -
Khatib Mohamad Y.,
Allafi Solaiman M.,
Nashwan Abdulqadir J.
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3642
Subject(s) - medicine , rituximab , pemphigus vulgaris , rash , myalgia , serum sickness , adverse effect , dermatology , immunology , antibody
Abstract Serum sickness, a reaction presenting with a classic triad (fever, rash, myalgia/arthralgia), is considered as a rare adverse event following monoclonal antibodies and specifically following treatment with rituximab. This report describes a case of serum sickness in a newly treated young male patient with rituximab for pemphigus vulgaris.